Overview
Astera Cancer Care (ACC) is a multispecialty medical practice that treats cancer and blood disorders. It brings together medical oncologists, radiation oncologists, and breast surgeons who work across 14 locations in New Jersey and one in Pennsylvania. ACC offers standard and advanced cancer therapies, including chemotherapy, biologic therapy, immunotherapy, and radiopharmaceuticals, and provides a wide range of radiation treatments such as proton therapy, prostate brachytherapy, and radiosurgery. The group also runs a clinical trials program, including one of the few community-based CAR-T cell trial programs in the United States. In addition to treatment, ACC leads in value-based oncology care and develops alternative payment models to reduce costs and improve outcomes for patients.
Work here?Claim your company
Simplify's take
What believers are saying
- Updated 2026-10-21 trials page shows active ALLO-329 enrollment infrastructure.
- Saint Peter’s partnership comment on 2026-10-06 validates Astera’s referral power and reputation.
- Astera’s 2026 blogs and East Brunswick opening signal continued patient demand and hiring need.
What critics are saying
- ALPHA3 depends on Allogene’s cema-cel and PhasED-Seq; trial delays crush differentiation.
- Saint Peter’s called Astera the largest central New Jersey oncology group, inviting integration risk.
- Community oncology reimbursement pressure can squeeze margins and force physician departures within 2027.
What makes Astera Cancer Care unique
- Astera runs one of New Jersey’s broadest community oncology footprints, spanning 14 locations.
- Astera opened East Brunswick at 629 Cranbury Road on 2026-11-02.
- Astera keeps rare community CAR-T access through ALPHA3, first U.S. site opened.
Help us improve and share your feedback! Did you find this helpful?